Can a Fistula Be Cured Permanently Without Surgery?

Can a fistula truly heal without surgery? Explore non-invasive options, their effectiveness, and when expert medical guidance is vital for lasting resolution.

Most fistulas cannot be permanently cured without some form of procedure, but the answer depends heavily on what type of fistula you have, what caused it, and how complex it is. The standard treatment for anal fistulas, which are the most common kind people ask about, remains surgical. However, a growing number of non-cutting and minimally invasive alternatives now exist, and certain fistulas that develop after abdominal surgery sometimes close on their own with the right supportive care. The honest picture is more nuanced than a simple yes or no.

When Fistulas Sometimes Close on Their Own

Enterocutaneous fistulas, which are abnormal connections between the intestine and the skin surface, often develop after abdominal surgery. Unlike anal fistulas, these have a realistic chance of closing without an operation. The standard approach involves bowel rest, nutritional support through intravenous feeding, and sometimes medications that reduce intestinal secretions. A meta-analysis looking at somatostatin and its synthetic versions found that somatostatin itself was linked to significantly higher rates of spontaneous closure and faster healing times, while octreotide (a commonly used synthetic version) sped up closure but did not clearly increase the overall chance of the fistula shutting on its own. In one study, spontaneous closure happened in about 60 percent of patients receiving octreotide alongside intravenous nutrition, though the closure rate was statistically similar to patients who received nutrition support alone.

Vesicovaginal fistulas, which connect the bladder to the vagina, are another type where doctors sometimes try conservative management first. The usual approach involves placing a catheter for continuous bladder drainage, sometimes for weeks, hoping the tissue heals. But in one study where all patients underwent two months of catheter drainage, every single case failed to close spontaneously because the fistulas were complex. Small, recently formed vesicovaginal fistulas do sometimes close with catheter drainage alone, but larger or older ones rarely do.

Anal fistulas, in contrast, almost never resolve without intervention. The tissue lining the tract tends to prevent it from collapsing and sealing shut the way a wound normally heals. If you have been diagnosed with an anal fistula and are hoping it will go away on its own, the evidence strongly suggests it will not.

Medications for Crohn’s-Related Fistulas

Fistulas caused by Crohn’s disease occupy a somewhat different category. Because Crohn’s is a chronic inflammatory condition, controlling the underlying inflammation can sometimes control the fistula. This is genuinely non-surgical treatment, though “controlled” and “permanently cured” are not the same thing.

Infliximab, a biologic drug that blocks a key inflammatory protein, is the best-studied medication for Crohn’s perianal fistulas. In a landmark trial, about 36 percent of patients on maintenance infliximab had complete absence of draining fistulas at one year, compared with 19 percent on placebo. A more recent comparison found that roughly 65 percent of patients starting infliximab showed clinical improvement at six months, compared with about 35 percent of those on adalimumab, another biologic. These numbers are encouraging, but they also show that most patients on biologic therapy do not achieve lasting fistula closure with medication alone. And many who do respond initially see their fistulas reopen when treatment is stopped or loses effectiveness over time.

Antibiotics are another option doctors use, though the evidence is thinner. In one trial of Crohn’s perianal fistulas, about half of patients responded to antibiotic treatment, but complete healing occurred in only a quarter at eight weeks. A small pilot study comparing ciprofloxacin, metronidazole, and placebo found remission in 30 percent of the ciprofloxacin group but zero percent of the metronidazole group after ten weeks, though the study was too small to draw firm conclusions. Antibiotics are best thought of as a bridge or a complement to other therapies rather than a standalone cure.

Fibrin Glue

Fibrin glue is a biological sealant injected directly into the fistula tract. The idea is simple: fill the tunnel with a substance that promotes clotting and tissue healing, essentially gluing it shut from the inside. No sphincter muscle is cut, which makes it appealing for patients worried about incontinence.

Results are mixed and depend heavily on the type of fistula. A prospective study found an initial success rate near 87 percent, but recurrence brought the long-term success rate down to about 63 percent. The treatment worked best for longer, unbranched tracts. Another study broke this down further: low fistulas with a single tract healed at 100 percent, while high fistulas with recurrent disease failed at 86 percent.

For Crohn’s patients specifically, a randomized trial found that fibrin glue produced clinical remission in 38 percent of patients at eight weeks, compared with 16 percent in those who received no treatment. The benefit appeared greater in patients with simple fistulas than complex ones, and most patients who achieved remission at eight weeks held onto it at sixteen weeks. Fibrin glue is safe and repeatable, but it is not a reliable permanent fix for most complex fistulas.

Biological Plugs

Anal fistula plugs are cone-shaped inserts made from biological materials like processed pig intestine or human acellular dermal matrix. A surgeon places the plug into the fistula tract to block it and encourage tissue growth around it. The procedure is quick, preserves the sphincter, and causes minimal pain.

Long-term outcomes, though, are variable. A study tracking patients for a median of eight years found an overall healing rate of 56 percent for low trans-sphincteric fistulas treated with plugs made from human acellular dermal matrix. A Danish study of patients with complex fistulas reported an initial healing rate of about 53 percent but an overall success rate of only 39 percent once recurrences were accounted for. One advantage noted in a review is that plugs made from acellular dermal matrix had significantly lower recurrence rates than traditional surgery. Even when plugs fail, they do not burn any bridges. You can try again or move on to conventional surgery.

A study that compared fistula plugs head-to-head with the surgeon’s preferred operation found nearly identical healing rates (54 percent vs. 55 percent) and no difference in quality of life at one year, though the plug approach cost more and caused slightly more unexpected pain in the early weeks.

Stem Cell Therapy

The most genuinely novel non-surgical approach involves injecting stem cells derived from fat tissue directly into the fistula tract. Darvadstrocel (marketed as Alofisel in Europe) is the first such therapy approved for treating complex perianal fistulas in Crohn’s disease. A systematic review of the evidence found it was superior to placebo for both clinical and imaging improvement in the short and long term.

A broader meta-analysis of randomized trials confirmed that adipose-derived stem cells improved both short-term and one-year clinical outcomes compared with conventional treatment for complex perianal fistulas. This is one of the few areas where the evidence genuinely points toward a non-surgical approach that can match or outperform conventional therapy for difficult cases. Availability is still limited and the treatment is expensive, but it represents a real shift in what is possible without cutting.

Laser Closure

Fistula laser closure, known as FiLaC, involves threading a laser fiber through the fistula tract and using thermal energy to destroy the lining and seal the tunnel shut. It preserves the sphincter muscle entirely and is performed as a day procedure. It is indicated for complex anal fistulas where traditional cutting surgery carries a higher risk of incontinence. While technically a procedure, it is about as far from traditional fistula surgery as you can get while still doing something physical to the tract. Success rates vary across studies, and as with plugs and glue, recurrence remains a real possibility.

Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurized chamber, which floods tissues with far more oxygen than they would normally receive. The oxygen-rich environment promotes anti-inflammatory effects and stimulates growth factors involved in wound healing. The concept is being explored specifically for complex perineal fistulas that keep coming back after surgery. This approach is still early in its evaluation and is best understood as an adjunct to other treatments rather than a standalone cure. You would not typically use HBOT instead of surgery; you might use it alongside surgery to improve healing in cases that have already failed once.

Why Fistula Complexity Changes Everything

The single biggest reason there is no clean yes-or-no answer to whether fistulas can be cured without surgery is that “fistula” covers a huge range of conditions. A simple, low-lying fistula that passes beneath a small amount of sphincter muscle is a completely different clinical problem from a high, branching tract that winds through the entire sphincter complex.

Fistulas are broadly classified as simple or complex based on how much sphincter muscle they involve. Simple fistulas cross less than about 30 percent of the external sphincter, while complex ones involve more. Some classification systems go further, grading fistulas on a five-point scale of increasing complexity. This matters because virtually every non-surgical treatment performs better on simple fistulas and worse on complex ones, as the fibrin glue data showed clearly.

A large meta-analysis of recurrence risk factors identified several features that make any treatment more likely to fail. High trans-sphincteric fistulas had nearly five times the recurrence risk of simpler ones. Fistulas where the internal opening could not be identified had more than eight times the recurrence risk. Branching tracts, prior surgery, and seton placement were also associated with higher failure rates. These risk factors apply to surgical and non-surgical approaches alike. If your fistula is simple and straightforward, non-surgical options have their best shot. If it is complex, multilayered, or recurrent, the odds tilt firmly toward needing a surgical procedure at some point.

The Ksharasutra Approach

Ksharasutra is an Ayurvedic technique that has been used in South Asia for centuries and is sometimes described as a non-surgical option for anal fistulas. In practice, it sits somewhere between surgery and conservative care. A medicated thread is passed through the fistula tract and gradually tightened over weeks, slowly cutting through tissue while simultaneously cauterizing and healing as it goes. A meta-analysis of available studies found it offered a promising cure rate with low incontinence and low recurrence.

A direct comparison with open surgery (fistulotomy) found that ksharasutra caused less severe pain and required far less time off work (about three days compared with more than two weeks), though healing took longer overall (about 53 days vs. 36 days). It left no open wound, in contrast to the surgical group, and was significantly cheaper. For patients who want to avoid a conventional operating room experience, this is an established option in countries where trained practitioners are available, though it does still physically divide tissue and is not truly non-invasive.

The Hidden Problem With “Healed”

One of the trickiest aspects of fistula treatment is defining what “cured” actually means. A fistula can stop draining and appear clinically healed while the tract underneath remains open. An audit of over 1,300 MRI scans found that imaging detected complications even in fistula tracts that appeared to have healed based on external examination. This is important because it means some reported “success” rates for non-surgical treatments may look better than they truly are if they rely only on external assessment rather than imaging confirmation.

This gap between surface appearance and actual healing is one reason recurrence rates are so stubbornly high across all treatment types. A fistula you thought was cured can reopen months or years later because the underlying tract never fully sealed. When evaluating whether any particular therapy can permanently cure a fistula, it is worth keeping in mind that permanent in this context is a high bar to clear.

What Happens If You Do Nothing

Some people ask about non-surgical cures because they want to avoid treatment altogether. This is understandable but risky. A fistula that is simply left alone typically does not heal and may worsen over time. Chronic untreated anal fistulas cause ongoing pain, discharge, and repeated infections. There is also a small but real risk that a long-standing chronic fistula undergoes malignant transformation. Case reports have documented squamous cell carcinoma arising in the setting of a chronic untreated anal fistula. Conventional surgical treatment itself carries recurrence rates that can range up to about 27 percent and incontinence risks between 5 and 40 percent depending on the procedure. These numbers explain why patients look for alternatives. But avoiding treatment entirely trades short-term discomfort for long-term deterioration in most cases.

The Cost Question

Even when non-surgical treatments work, cost can be a barrier. An economic analysis of medical management for Crohn’s perianal fistulas found that while infliximab was slightly more effective than combination antibiotic-plus-immunosuppressant therapy, it was dramatically more expensive, with incremental costs exceeding $350,000 per quality-adjusted life year. Stem cell therapy and hyperbaric oxygen are also costly and may not be covered by insurance. By contrast, traditional surgery and approaches like ksharasutra are comparatively affordable. For many patients, the practical question is not just “can I avoid surgery?” but “can I afford the alternatives?”

Supportive measures like sitz baths, fiber optimization, and hydration are essentially free and can help manage symptoms and support healing alongside other treatments. A case report documented complete resolution of recurrent fistula symptoms using a structured regimen of neem-based sitz baths, dietary fiber, hydration, and mechanical offloading, without any procedural intervention. These kinds of supportive strategies are better understood as symptom management and healing optimization rather than standalone cures, but they are worth incorporating into whatever treatment plan you and your doctor settle on.